Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Grace Therapeutics Inc.
Grace Therapeutics Inc.
Industry · 8 registered clinical trials.
Status
Trial
Phase
Started
Active Not Recruiting
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Aneurysmal Subarachnoid Hemorrhage (aSAH)
Phase 3
2023-10-20
Unknown
Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
Ataxia Telangiectasia
Phase 1
2022-09-13
Unknown
Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Sub
Postherpetic Neuralgia
Phase 1
2022-07-26
Completed
Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects
Aneurysmal Subarachnoid Hemorrhage
Phase 1
2021-08-26
Completed
A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)
Hypertriglyceridemia
Phase 3
2018-02-01
Completed
A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)
Hypertriglyceridemia
Phase 3
2018-01-23
Completed
Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia
Hypertriglyceridemia
Phase 2
2011-12-01
Completed
TRIal For Efficacy of Capre on hyperTriglyceridemiA
Hypertriglyceridemia
Phase 2
2011-09-01